Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2020
Source ID
10.1038/s41588-020-0630-5

Entities

People

  • Alejandro Jiménez-Sánchez
  • Alexandra Snyder
  • Anastasios D. Papanastasiou
  • Britta Weigelt
  • Danish Memon
  • Dennis S. Chi
  • Dmitriy Zamarin
  • Dominique-Laurent Couturier
  • Evis Sala
  • Felipe C. Geyer
  • Florian Markowetz
  • Geoff Macintyre
  • Hebert Alberto Vargas
  • Ines Nikolovski
  • James D Brenton
  • Jorge S Reis-Filho
  • Katherine Lavigne Mager
  • Kay J. Park
  • Lena Morrill Gavarró
  • Martin L Miller
  • Michael B. Gill
  • Oliver Cast
  • Paulina Cybulska
  • Pedro Beltrao
  • Pier Selenica
  • Ramon E. Sosa
  • Robert A. Soslow
  • Ronglai Shen
  • Ruben M. Drews
  • Simon Koplev
  • Travis J. Hollmann
  • Tyler Walther
  • Yonina Bykov
  • Yousef Mazaheri

Organizations

  • Cancer Research UK
  • Carlos III Health Institute
  • Congressionally Directed Medical Research Programs
  • European Bioinformatics Institute
  • Ovarian Cancer Research Alliance
  • Society of Memorial Sloan Kettering
  • Target Ovarian Cancer
  • The Breast Cancer Research Foundation
  • University of Cambridge
  • Wellcome Trust